Results 101 to 110 of about 1,282,511 (265)
Kounis Syndrome Associated With Selective Anaphylaxis to Cefazolin. [PDF]
, 2018 info:eu-repo/semantics ...
Chambel, M +5 more
core +1 more source
Genomics and Histopathology in Interstitial Cystitis/Bladder Pain Syndrome
Neurourology and Urodynamics, Volume 45, Issue 1, Page 54-59, January 2026.ABSTRACT Aims In April of 2025, a Global Consensus meeting on IC/BPS was held in Winston‐Salem, NC. The goal of this meeting was to establish global consensus in diagnostic criteria, phenotyping, treatment outcome assessment, and possible etiopathology in interstitial cystitis/bladder pain syndrome (IC/BPS).
Hannah Ruetten +4 more
wiley +1 more source
Case Report: Treatment of systemic mastocytosis with sunitinib [version 1; referees: 2 approved]
F1000Research, 2017 Mast cell activation disease typically presents as chronic multisystem polymorbidity of generally inflammatory ± allergic theme. Presently, treatment of the rare, cytoproliferative variant systemic mastocytosis employs empirically selected therapies to ...
Gerhard J. Molderings +3 more
doaj +1 more source
Implementing PEN‐FAST for penicillin allergy delabeling in a high‐prevalence population
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 1, Page 57-63, January 2026.Summary Background and objectives Self‐reported penicillin allergies lead to the use of broad‐spectrum antibiotics, increase drug resistance, and constitute an economic burden. The PEN‐FAST score aims to identify low‐risk patients for direct drug provocation tests (DPT) without prior skin testing with a reported negative predictive value (NPV) of over ...
Deniz Göcebe +4 more
wiley +1 more source
Experimental and clinical study of the efficacy of medicines containing omega-3 and 6 polyunsaturated fatty acids, in the treatment of inflammatory skin diseases [PDF]
, 2018 Over the recent years, the attention of scientists regarding the search for alternative means of treatment, including local therapy, of inflammatory skin diseases, has been focused in recent years on medicines containing omega-3 and 6 polyunsaturated ...
Grebennikova, S. V., Maklyakov, Y. S.
core +3 more sources
Allergy. European Journal of Allergy and Clinical Immunology, 2020 In indolent systemic mastocytosis (ISM), several risk factors of disease progression have been identified. Previous studies, performed with limited patient numbers, have also shown that the clinical course in ISM is stable and comparable to that of ...
J. Trizuljak +42 more
semanticscholar +1 more source
Expanding the Immunologic and Neuronal Landscape of IgE‐Mediated Anaphylaxis
Immunological Reviews, Volume 337, Issue 1, January 2026.ABSTRACT Anaphylaxis is a life‐threatening immunoglobulin E (IgE)‐mediated type I hypersensitivity reaction with rising prevalence and burden. It involves mast cell degranulation upon cross‐linking of antigen on mast cell‐bound IgE. Mechanisms of IgE‐mediated anaphylaxis remain incompletely understood, particularly the induction of systemic symptoms ...
Ruchi Biswas +2 more
wiley +1 more source
Case Reports in Hematology, Volume 2026, Issue 1, 2026.Systemic mastocytosis (SM) with associated hematological neoplasia (SM‐AHN) is a rare and aggressive condition characterized by abnormal clonal proliferation of mast cells and the concurrent occurrence of hematologic malignancies, such as acute myeloid leukemia (AML).
Sona Vardanyan +6 more
wiley +1 more source
Systemic Mastocytosis Presenting as Acute Appendicitis: A Case Report and Review of the Literature
Case Reports in Oncology, 2013 Systemic mastocytosis is characterized by abnormal growth and accumulation of mast cells in various organs. Gastrointestinal (GI) symptoms are common disease manifestations in this disease and can significantly impair the quality of life.
Syed A. Akbar +4 more
doaj +1 more source